(Q80113429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Activated NKT cells increase dendritic cell migration and enhance CD8+ T cell responses in the skin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

Anton V Gorbachev

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Robert L Fairchild

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

2494-2503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

NKT cells: facts, functions and fallacies.

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Recognition of bacterial glycosphingolipids by natural killer T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

CD1d1-dependent control of the magnitude of an acute antiviral immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

CD8+ T cells produce IL-2, which is required for CD(4+)CD25+ T cell regulation of effector CD8+ T cell development for contact hypersensitivity responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Distinct functional lineages of human V(alpha)24 natural killer T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Involvement of decidual Valpha14 NKT cells in abortion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636075

7 January 2021

Identifiers

DOI

10.1002/EJI.200636075

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16909435%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference